Latest filing published 18 Mar 2020 for Corbus Pharmaceuticals Holdings, Inc., €9,006.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 3 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -46.2%Entry US$131.10 · Close at T+365 US$70.50
- -67.8%Entry US$128.70 · Close at T+365 US$41.40
- +16.6%Entry US$183.00 · Close at T+365 US$213.30
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Robert Paul Discordia: trading record in brief
This profile gathers the share dealings of Robert Paul Discordia in Corbus Pharmaceuticals Holdings, Inc. Over a trading history stretching from 12 August 2019 to 17 March 2020, the count stands at 3 filings.
No open-market sale appears; the market trades are 3 purchases worth €98k. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2020 alone, the filings show 1 purchase and no sales.
In size, the median ticket on the buying side is €10k. Of 3 purchases, 3 formed part of a group of insiders buying within 30 days of each other. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. Looking at 3 purchases old enough to measure, the stock rose over the following 90 days in 67% of cases; the median change was +47.1%. Past outcomes like these are no guarantee of what comes next.
The record was last updated on 18 March 2020 with an open-market purchase (€9,006) in Corbus Pharmaceuticals Holdings, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Robert Paul Discordia
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,840 shares@ US$3.549.2% of flowCommon StockSEC:0001209191-20-019931:0Canonical exit: 15 Jun 2020 (T+90)
- 2,500 shares@ US$4.6210.7% of flowCommon StockSEC:0001209191-19-055918:0Canonical exit: 9 Feb 2020 (T+90)
- 15,000 shares@ US$5.8680.1% of flowCommon StockSEC:0001209191-19-045442:0Canonical exit: 10 Nov 2019 (T+90)
3 of 3 declarations